R&D

Principle of research and development, and drug discovery policy

On a mission to "contribute to society by developing pharmaceutical products that bring true benefit to patients," we are making every effort to develop original and innovative new drugs to treat incurable diseases and address the areas with high medical needs where patients are not satisfied with existing products.

Characteristics of research and development

Based on our unique drug discovery approach, "Compound Orient," we aim to create new drugs that will bring innovation to the medical field by focusing on disease areas with high medical needs. To this end, we will strengthen and expand research and drug discovery alliances with world-leading universities, research institutes, and bio-venture companies in specific research fields, introduce innovative compounds in fields with high medical needs, and introduce new technologies. We are also actively promoting acquisition.

 

In-house
Drug Discovery

 

Open
Innovation

 

Licensing
Activities

 
 

In-house
Drug Discovery

 
 

Open
Innovation

 
 

Licensing
Activities

Research and development bases/system

 

Research
Organization

Flexible thinking helps research advance. Researchers with cutting-edge technology from different fields gather and form project teams to exchange information and opinion and inspire with each other.

 

Development
Organization

By reinforcing the bases of new drug development in Japan, Asia, the U.S. and Europe, we are aiming at efficient global collaboration, speedy clinical development and new drug application/approval in the U.S. and Europe as well as Japan and Asia.

 

Development
Pipeline

Guidelines